CD8+ T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated Antigens
Neal D. Shore, Matthew P. Morrow, Trevor McMullan, Kimberly A. Kraynyak, Albert J. Sylvester, Khamal Bhatt, Jocelyn Cheung, Jean Boyer, Li Liu, Brian Sacchetta, Samantha Rosencranz, E. Heath, Luke T. Nordquist, Heather H. Cheng, Scott T. Tagawa, Leonard J. Appleman, Ronald Tutrone, Jorge A. García, Young E. Whang, William Kevin Kelly, David B. Weiner, Mark L. Bagarazzi, Jeffrey M. Skolnik
Topics & Concepts
MedicineProstate cancerProstate-specific antigenElectroporationAntigenUrologyImmunotherapyImmunogenicityInternal medicineGlutamate carboxypeptidase IIOncologySurgeryCancerImmunologyBiologyGeneBiochemistryImmunotherapy and Immune ResponsesCAR-T cell therapy researchCancer Immunotherapy and Biomarkers